Johnson and Johnson - What's Driving the Revenue?

Johnson and Johnson will be the biggest pharmaceutical in the world when it spins off its consumer health business. The company's top three drugs are around 22%. And that means they have a really diversified pharma pipeline, which is what I like the most about J&J. But the biggest risk for me actually is just that the company depends so much on sales of one or two drugs,. It's now $51 in a bit on Monday, but I hope to have it by next week.